2007
DOI: 10.1016/j.jmb.2007.08.042
|View full text |Cite
|
Sign up to set email alerts
|

Structural Basis of the Zinc Inhibition of Human Tissue Kallikrein 5

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
58
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 78 publications
(63 citation statements)
references
References 54 publications
5
58
0
Order By: Relevance
“…way, along with the sensitivity of these proteases to serpinor Kazal-type inhibitors, and to divalent ions (Borgono and Diamandis, 2004;Debela et al, 2006aDebela et al, , 2007. In contrast to the well-known coagulation cascade that consists of sequential proteolytic activations, KLKs seem to be rather integrated within a proteolytic network which involves a large array of (pro-)proteases, with no clear hierarchy.…”
Section: Discussionmentioning
confidence: 99%
“…way, along with the sensitivity of these proteases to serpinor Kazal-type inhibitors, and to divalent ions (Borgono and Diamandis, 2004;Debela et al, 2006aDebela et al, , 2007. In contrast to the well-known coagulation cascade that consists of sequential proteolytic activations, KLKs seem to be rather integrated within a proteolytic network which involves a large array of (pro-)proteases, with no clear hierarchy.…”
Section: Discussionmentioning
confidence: 99%
“…Yeast-expressed KLK5 appeared to be glycosylated with molecular masses from 30 to 44 kDa, which turned over tryptic substrates like VPR-AMC; PNGase F treatment reduced the mass to 26 or 28 kDa, respectively Michael et al, 2005). The two GlcNAc residues that are well defined in the electron density in the insect cell-expressed KLK5 crystal structure are located in a solvent exposed region of a β-sheet distant from the active site, similar to the three other potential sites (2PSX, Figure 3) (Mekdes Debela et al, 2007a).…”
Section: The Epidermal Klks 5 7 and 14mentioning
confidence: 91%
“…Moreover, Zn 2+ inhibits KLK5 (Debela et al 2007). This might have clinical consequences, when Zink levels are low as in acrodermatits enteropathica.…”
Section: Other Regulating Factors Of Protease Activitymentioning
confidence: 97%